Nowadays, the anti-TNF based therapy is widely used and approved for the treatment of chronic inflammatory conditions as rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, plaque psoriasis and psoriatic arthritis, ankylosing spondylitis and inflammatory bowel diseases [2]. This evidence concerns the gene TNF and rheumatoid arthritis.